{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:19:17Z","timestamp":1770513557288,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1CA173887"],"award-info":[{"award-number":["RO1CA173887"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM102989"],"award-info":[{"award-number":["R01GM102989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21CA173887"],"award-info":[{"award-number":["R21CA173887"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.actbio.2016.07.014","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T19:16:19Z","timestamp":1468610179000},"page":"282-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel"],"prefix":"10.1016","volume":"43","author":[{"given":"Jingjing","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.07.014_b0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.actbio.2016.07.014_b0010","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1016\/S0009-2509(03)00234-3","article-title":"Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases","volume":"58","author":"Feng","year":"2003","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.actbio.2016.07.014_b0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:DRUG.0000047106.20104.a7","article-title":"Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors","volume":"23","author":"El-Rayes","year":"2005","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.actbio.2016.07.014_b0020","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1039\/C4PY01422G","article-title":"Paclitaxel-loaded cholesterol-conjugated polyoxyethylene sorbitol oleate polymeric micelles for glioblastoma therapy across the blood-brain barrier","volume":"6","author":"Li","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1039\/C3TB21016B","article-title":"Recent advances in hydrogel based drug delivery systems for the human body","volume":"2","author":"Vashist","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2016.07.014_b0030","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1021\/bm400615n","article-title":"Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy","volume":"14","author":"Gu","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.07.014_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2016.07.014_b0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2012.08.012","article-title":"Polymer therapeutics-prospects for 21st century: the end of the beginning","volume":"65","author":"Duncan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2016.07.014_b0045","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/mp300729y","article-title":"Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel","volume":"10","author":"Lu","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2016.07.014_b0050","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.biomaterials.2012.10.073","article-title":"PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers","volume":"34","author":"Lu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.07.014_b0055","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1208\/s12248-014-9595-6","article-title":"Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system","volume":"16","author":"Chen","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.actbio.2016.07.014_b0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2013.01.035","article-title":"Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer","volume":"169","author":"Mi","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2016.07.014_b0065","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1021\/nn405674m","article-title":"Nanoparticles for combination drug therapy","volume":"7","author":"Ma","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2016.07.014_b0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biomaterials.2015.03.006","article-title":"Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer","volume":"53","author":"Noh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.07.014_b0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0076-6879(07)00432-6","article-title":"The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer","volume":"439","author":"Rotblat","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.actbio.2016.07.014_b0080","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1074\/jbc.274.3.1606","article-title":"Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling evidence from lateral mobility studies","volume":"274","author":"Niv","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0085","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/bi972032d","article-title":"Dislodgment and accelerated degradation of Ras","volume":"37","author":"Haklai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.actbio.2016.07.014_b0090","doi-asserted-by":"crossref","first-page":"22263","DOI":"10.1074\/jbc.270.38.22263","article-title":"Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid","volume":"270","author":"Marom","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1357-4310(00)01789-5","article-title":"RAS inhibitors: potential for cancer therapeutics","volume":"6","author":"Kloog","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.actbio.2016.07.014_b0100","first-page":"555","article-title":"The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance","volume":"8","author":"Gana-Weisz","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2016.07.014_b0105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s10753-012-9488-8","article-title":"Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T Cells independent of prostaglandin E2 production","volume":"35","author":"Mor","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.actbio.2016.07.014_b0110","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/0929867311320100002","article-title":"Immunomodulatory properties of farnesoids: the new steroids?","volume":"20","author":"Mor","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/JTO.0b013e318223c099","article-title":"A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations","volume":"6","author":"Riely","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.actbio.2016.07.014_b0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clml.2015.02.018","article-title":"Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies","volume":"15","author":"Badar","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.actbio.2016.07.014_b0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1021\/bc300608h","article-title":"PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel","volume":"24","author":"Zhang","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0130","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1021\/bm501339j","article-title":"Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif","volume":"15","author":"Zhang","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.07.014_b0135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/acsmacrolett.5b00165","article-title":"Tunable pH-responsive polymeric micelle for cancer treatment","volume":"4","author":"Zhang","year":"2015","journal-title":"ACS Macro Lett."},{"issue":"2011","key":"10.1016\/j.actbio.2016.07.014_b0140","first-page":"4058","article-title":"Formulation of docetaxel by folic acid-conjugated d-\u03b1-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS 2k) micelles for targeted and synergistic chemotherapy","volume":"32","author":"Mi","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.07.014_b0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actbio.2016.07.014_b0150","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1021\/ma2016503","article-title":"Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a michael addition for cis-platinum drug delivery","volume":"44","author":"Huynh","year":"2011","journal-title":"Macromolecules"},{"issue":"2012","key":"10.1016\/j.actbio.2016.07.014_b0155","first-page":"6877","article-title":"Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance","volume":"33","author":"Wang","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.07.014_b0160","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1021\/mp500181x","article-title":"PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel","volume":"11","author":"Zhang","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2016.07.014_b0165","doi-asserted-by":"crossref","first-page":"17560","DOI":"10.1021\/ja207150n","article-title":"Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery","volume":"133","author":"Du","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2016.07.014_b0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jconrel.2015.09.043","article-title":"Polymeric drugs: advances in the development of pharmacologically active polymers","volume":"219","author":"Li","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2016.07.014_b0175","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1039\/C3PY01384G","article-title":"Recent trends in the design of anticancer polymer prodrug nanocarriers","volume":"5","author":"Delplace","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0180","first-page":"419","article-title":"Bioactive and therapeutic ROMP polymers","volume":"47","author":"Smith","year":"2007","journal-title":"J. Macromol. Sci. Polym. Rev."},{"key":"10.1016\/j.actbio.2016.07.014_b0185","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/bm4009149","article-title":"Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization","volume":"14","author":"Hasegawa","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.07.014_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/adhm.201400148","article-title":"Polymers fight HIV: potent prodrugs identified through parallel automated synthesis","volume":"4","author":"Zuwala","year":"2015","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.actbio.2016.07.014_b0195","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/adhm.201300637","article-title":"Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drug","volume":"3","author":"Smith","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.actbio.2016.07.014_b0200","article-title":"Two-photon degradable supramolecular assemblies of linear-dendritic copolymers","volume":"2081\u20132082","author":"Mynar","year":"2007","journal-title":"Chem. Commun."},{"key":"10.1016\/j.actbio.2016.07.014_b0205","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/ja809475a","article-title":"Multi-stimuli sensitive amphiphilic block copolymer assemblies","volume":"131","author":"Klaikherd","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actbio.2016.07.014_b0210","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/bc3000468","article-title":"PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel","volume":"23","author":"Huang","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2016.07.014_b0215","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1016\/j.biomaterials.2014.04.108","article-title":"A PEG-Fmoc conjugate as a nanocarrier for paclitaxel","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.07.014_b0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nano.2011.06.009","article-title":"In vivo cancer imaging by poly (ethylene glycol)-b-poly (\u025b-caprolactone) micelles containing a near-infrared probe","volume":"8","author":"Cho","year":"2012","journal-title":"Nanomedicine NBM"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116303324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116303324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:52:00Z","timestamp":1761670320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116303324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":44,"alternative-id":["S1742706116303324"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.07.014","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}